Back to News
quantum-computing

QMatter Secures $1.2M Pre-Seed to Create Software that Compresses Complex Quantum Problems to their Essential Core

Quantum Computing Report
Loading...
2 min read
0 likes
⚡ Quantum Brief
Quantum software startup QMatter raised $1.2M in pre-seed funding led by 55 North, with participation from XTX Ventures and others, to develop its quantum compression platform. The company’s proprietary technology shrinks complex quantum problems before processing, enabling high-dimensional simulations on current limited hardware while accelerating classical supercomputer algorithms. QMatter targets two key sectors: pharma/biotech R&D, where it provides high-fidelity simulations to speed drug discovery, and AI training, offering physics-informed datasets for machine learning models. Founded by former UCL and Tufts researchers, the UK/US-based startup applies quantum mechanics to compress problems, bridging the gap between today’s hardware constraints and advanced computational needs. The funding will advance its platform, aiming to make quantum-enhanced simulations practical for industries reliant on large-scale, high-precision computational workflows.
QMatter Secures $1.2M Pre-Seed to Create Software that Compresses Complex Quantum Problems to their Essential Core

Summarize this article with:

QMatter Secures $1.2M Pre-Seed to Create Software that Compresses Complex Quantum Problems to their Essential Core Qmatter co-founders Dr. Tim Weaving (left) and Dr. Alexis Ralli (right). Quantum software startup QMatter has announced a $1.2 million pre-seed funding round to advance its proprietary quantum compression platform. The round was led by 55 North with participation from XTX Ventures, Bellstate Oy, and the Conception X Angel Syndicate. QMatter’s approach involves quantum compression—a method that applies quantum mechanical principles to “shrink” a problem’s size before it reaches the processor. This allows complex, high-dimensional simulations to fit within the constraints of today’s limited hardware while simultaneously accelerating classical algorithms on supercomputers. The company is targetting their roadmap to focus on two key areas: Pharma/Biotech R&D: For providing high-fidelity simulation data to accelerate drug discovery workflows. AI Training: For generating physics-informed data libraries to help machine learning companies train models on previously inaccessible, problem-specific datasets. QMatter is a UK/US‑based company founded by former researchers from University College London and Tufts University. A press release with additional details has been posted on the company’s website here. April 22, 2026 dougfinke2026-04-22T17:06:24-07:00 Leave A Comment Cancel replyComment Type in the text displayed above Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.

Read Original

Tags

drug-discovery
quantum-investment
quantum-software
startup

Source Information

Source: Quantum Computing Report